Nov 5, 2025 07:15AM Biomea Fusion Inc. (BMEA) PT Lowered to $12 at D. Boral Capital

Nov 4, 2025 05:40PM Biomea Fusion, Inc. (BMEA) Tops Q3 EPS by 2c

Oct 27, 2025 08:01AM Biomea Fusion doses first patient in obesity drug trial

Oct 14, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Biomea Fusion Inc. (BMEA)

Oct 6, 2025 04:03PM Biomea Fusion reports sustained diabetes treatment effects 9 months post-dosing

Sep 16, 2025 07:02AM Biomea Fusion presents preclinical data on diabetes drug combination

Aug 28, 2025 05:30AM Jefferies Starts Biomea Fusion Inc. (BMEA) at Buy

Aug 5, 2025 04:10PM Biomea Fusion, Inc. (BMEA) Tops Q2 EPS by 3c

Jun 24, 2025 06:49AM Biomea Fusion Inc. (BMEA) PT Lowered to $4 at H.C. Wainwright

Jun 17, 2025 04:34PM Biomea Fusion, Inc. (BMEA) Announces Proposed Share Offering

Jun 16, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Biomea Fusion Inc. (BMEA)

Jun 13, 2025 06:46AM Biomea Fusion, Inc. (BMEA) Presents Updated Preliminary Clinical Data for BMF-500

May 6, 2025 07:12AM Biomea Fusion Inc. (BMEA) PT Lowered to $18 at H.C. Wainwright

Mar 24, 2025 08:35AM Biomea Fusion, Inc. (BMEA): Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function

Dec 18, 2024 06:51AM H.C. Wainwright Reiterates Buy Rating on Biomea Fusion Inc. (BMEA)

Dec 17, 2024 08:10AM Biomea Fusion, Inc. (BMEA) Announces Positive Topline Results from Ongoing Phase II COVALENT-111 Study in Patients with Type 2 Diabetes

Dec 9, 2024 04:03PM Biomea Fusion (BMEA) Announces Preliminary Data from Ongoing COVALENT-103 Study of Investigational Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia

Oct 31, 2024 07:40AM Biomea Fusion Inc. (BMEA) PT Raised to $19 at Piper Sandler

Oct 29, 2024 04:48PM Biomea Fusion, Inc. (BMEA) Tops Q3 EPS by 3c

Oct 22, 2024 06:58AM H.C. Wainwright Reiterates Buy Rating on Biomea Fusion Inc. (BMEA)

Oct 21, 2024 09:04AM Biomea Fusion (BMEA) Announces Approval of "icovamenib" as International Nonproprietary Name for BMF-219

Oct 9, 2024 07:10AM EF Hutton Starts Biomea Fusion Inc. (BMEA) at Buy

Oct 1, 2024 09:03AM Biomea Fusion, Inc. (BMEA) Forms Global Scientific Advisory Board with 22 Diabetes Experts

Sep 27, 2024 09:47AM Increasing unusual option volume: BMEA TIGR ASHR MNSO MLCO MTN PHG KVYO WB ESTA YANG GEVO

Sep 27, 2024 09:10AM Biomea Fusion (BMEA) Gains 11%, Analysts Positive After FDA Lifts Clinical Holds on BMF-219 in Type 2 and Type 1 Diabetes Trials

Sep 27, 2024 09:07AM Biomea Fusion, Inc. (BMEA): FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials (Earlier)

Sep 27, 2024 08:41AM Piper Sandler Reiterates Overweight Rating on Biomea Fusion Inc. (BMEA)

Sep 27, 2024 08:18AM Biomea Fusion Inc. (BMEA) PT Raised to $41 at Scotiabank

Sep 27, 2024 06:44AM Biomea Fusion Inc. (BMEA) PT Raised to $40 at H.C. Wainwright

Sep 27, 2024 03:41AM Truist Securities Upgrades Biomea Fusion Inc. (BMEA) to Buy

Jun 11, 2024 03:36AM Truist Securities Downgrades Biomea Fusion Inc. (BMEA) to Hold

Jun 10, 2024 05:39AM Biomea Fusion Inc. (BMEA) PT Lowered to $15 at H.C. Wainwright